Brief: Sensorion Announces Completion Of Patient Enrollment
Nov 27 (Reuters) - SENSORION SA ALSEN.PA :
* SENSORION ANNOUNCES COMPLETION OF PATIENT ENROLLMENT AND
DOSING
IN SELIFORANT PHASE 2A STUDY
Source text for Eikon: ID:nBw4jpsqpa
Further company coverage: ALSEN.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Sensorion SA
See all newsEurope Research Roundup: Glencore, Hydro, SIG Group
Europe Research Roundup: Ashmore, Chemring Group, Qinetiq Group
Brief: Sensorion Says CEO Nawal Ouzren To Step Down
Analysis: Trump health policy uncertainty sends biotech sector into deeper slump
Brief: Sensorion Announces EUR 15 Mln Financing, Extending Cash Runway Until End 2025